Pseudostat oral therapeutic vaccine targeted at Pseudomonas aeruginosa: Phase II trial in Australia

Cortecs International Ltd. (DLVRY), London, U.K. Product: Pseudostat oral therapeutic vaccine targeted at Pseudomonas aeruginosa Indication: Cystic fibrosis Status: DLVRY began a Phase II trial in Au...